Log in to search using one of your social media accounts:

 

With Mission Bay and South S.F. filling up, biotech developers look to San Carlos
Alexandria Real Estate Equities' recent purchases of San Carlos property could signal a new era for biotech in the area. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 23, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

With Mission Bay and South S.F. filling up, biotech developers look to San Carlos
Alexandria Real Estate Equities' recent purchases of San Carlos property could signal a new era for biotech in the area. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 23, 2017 Category: American Health Authors: Ron Leuty Source Type: news

Oregon Obamacare signups running ahead of last year
From Nov. 1, the first day of open enrollment, to Nov. 18, 42,834 Oregonians cumulatively selected plans at HealthCare.gov. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

With Mission Bay and South S.F. filling up, biotech developers look to San Carlos for expansion
Alexandria Real Estate Equities' recent purchases of San Carlos property could signal a new era for biotech in the area. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Elderwood owners to acquire Weinberg Campus
The deal is the largest yet by Post Acute Partners in Western New York since the company acquired the Elderwood system. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Tracey Drury Source Type: news

With Mission Bay and South S.F. filling up, biotech developers look to San Carlos for expansion
Alexandria Real Estate Equities' recent purchases of San Carlos property could signal a new era for biotech in the area. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 22, 2017 Category: American Health Authors: Ron Leuty Source Type: news

GE Healthcare ups marketing for Waukesha-developed software that cuts MRI scan times
GE Healthcare ’s Waukesha engineering team played a major role in developing the company’s new magnetic-resonance-imaging technology that reduces scan time by 30 percent to 50 percent. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Rich Kirchen Source Type: news

California's uninsured rate hits lowest level ever
The number of people with health insurance hit a record high in the California this year, according to data from the Centers for Disease Control and Prevention released this week. California’s uninsured rate dropped from 7.2 percent in 2016 to 6.8 percent from January to June — outpacing the federal rate for states supported by the federal insurance marketplace, Healthcare.gov. “It was nice to see that California also had good company among states dramatically reduci ng their uninsured population,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Antoinette Siu Source Type: news

How Moffitt could play a role in finding a treatment for ovarian cancer
A California biotechnology company has signed an agreement with Moffitt Cancer Center in Tampa to do the research and development work for a potential immunotherapy to treat ovarian cancer. ITUS Corp. (NASDAQ: ITUS), based in San Jose, California, will pay Moffitt about $1.2 million over two years, as part of a cooperative research and development agreement, Amit Kuman, president and CEO of ITUS, said in a conference call Tuesday. Leading the work will be Dr. Jose Conejo Garcia, a M offitt researcher… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 22, 2017 Category: American Health Authors: Margie Manning Source Type: news

How Moffitt could play a role in finding a treatment for ovarian cancer
A California biotechnology company has signed an agreement with Moffitt Cancer Center in Tampa to do the research and development work for a potential immunotherapy to treat ovarian cancer. ITUS Corp. (NASDAQ: ITUS), based in San Jose, California, will pay Moffitt about $1.2 million over two years, as part of a cooperative research and development agreement, Amit Kuman, president and CEO of ITUS, said in a conference call Tuesday. Leading the work will be Dr. Jose Conejo Garcia, a M offitt researcher… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Margie Manning Source Type: news

EXCLUSIVE: New Swedish chief appoints COO, fills out C-suite
Swedish Health Services' new CEO Dr. Guy Hudson has added four new executives to his leadership team. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Coral Garnick Source Type: news

Company seeks approval for $2.08 million dialysis facility in Triad
Total Renal Care of North Carolina has applied for state approval to develop a 10-station dialysis facility in Guilford County.   The more than $2.08 million project would move seven stations from Reidsville Dialysis and three stations from Burlington Dialysis to a new facility, according to the certificate-of-need application. Total Renal Care, doing business as Guilford County Dialysis, is a subsidiary of DaVita Inc., based in Colorado. Wake Forest Health University Health Sciences, which owns… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Four questions for Sami Inkinen, CEO of Virta Health
Inkinen is best known in business for co-founding real estate site Trulia, which he helped shepherd through its IPO and its $3.5 billion sale to Zillow. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Kevin Truong Source Type: news

Judge sentences former WellCare top lawyer on false statements charge
A federal judge in Tampa has sentenced the former general counsel of WellCare Health Plans Inc. to six months in prison for making a false statement to the Florida Medicaid program. Thaddeus Bereday pleaded guilty in June, closing a chapter in a case that transformed WellCare (NYSE: WCG), the third-largest publicly traded company headquartered in Tampa Bay. Bereday was one of five former WellCare executives indicted in 2011, in what federal prosecutors said was a scheme to s ubmit inflated cost… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Margie Manning Source Type: news

KC Chamber dinner includes a generational changing of the guard [PHOTOS]
The Greater Kansas City Chamber of Commerce's annual dinner gathered the area's top business, civic and government leaders to look back at a year of accomplishments, ahead to new leadership and anoint a new Kansas Citian of the Year. A crowd estimated at 1,800 attended the Tuesday event to mark the passing of the chairman's position to a new person — and new generation. Matt Condon, who founded ARC Therapy + and Bardavon Health Innovations, succeeds Black& Veatch CFO Karen Daniel in the top position. Condon,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Brian Kaberline Source Type: news

FDA warns against ‘do it yourself’ gene therapy kits
The U.S. Food and Drug Administration has issued a stern warning against the use of “do it yourself” gene therapy kits, pushing back against a nascent “biohacker” movement that seeks to make experimental medicines and technologies available to the masses, often by circumventing regulators. A statement posted on the FDA’s website on Tuesday cautions that it is illegal to sell gene therapy products and kits intended for self-administration. Gene therapy involves inserting new, healthy genes… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

OhioHealth has a $3.6B nest egg to hedge against 'turmoil' in health care, help subsidize rural hospitals
OhioHealth Corp.'s unrestricted reserve fund grew by a half-billion this year to $3.64 billion – theoretically almost enough to let it go a year without revenue from patient care. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Carrie Ghose Source Type: news

Sneak peek: HCMC's new downtown $225M ambulatory care center (photos)
Hennepin County Medical Center gave the Business Journal an early look this week at its new $225 million downtown Minneapolis ambulatory outpatient specialty center, which has been under construction for about two years. HCMC will consolidate more than 40 clinics now spread across nine blocks at the 367,000-square-foot center. The building is on Eighth Street directly across from HCMC’s existing emergency department. Minneapolis-based HCMC expects the building to make care more convenient for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Katharine Grayson Source Type: news

M & A deals shake up Twin Cities health care market, but won't upend it
Consolidation continued to sweep through the Twin Cities health care market in 2017, though the deals have yet to change rankings on the Business Journal ’s Health Care Providers List. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Katharine Grayson Source Type: news

BOY spotlight: Dayton Children ’s Hospital (Customer Service)
The hospital is now seeing 300,000 visits a year from children in 20 counties in Southwest Ohio. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Tristan Navera Source Type: news

Strides arm gets USFDA nod for altitude sickness tablets
In a BSE filing, it said Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for Acteazolamide tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 22, 2017 Category: Pharmaceuticals Source Type: news

Cancer Center champion named Kansas Citian of the Year (Video)
The leader who has devoted more than a decade to ramping up Kansas City ’s cancer resources has been rewarded for his efforts by the Greater Kansas City Chamber of Commerce. Dr. Roy Jensen, director of The University of Kansas Cancer Center, was named as Kansas Citian of the Year by the chamber. He joins a long line of business leaders honored with the designation, i ncluding Hallmark Cards Inc. CEO Donald Hall Jr. and Burns& McDonnell CEO Greg Graves. “Dr. Jensen is passionate in his fight… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Elise Reuter Source Type: news

With FDA approval in sight, why Aerie's keen on global strategy too
With U.S. Food and Drug Administration approval potentially just around the corner, Aerie Pharmaceuticals (Nasdaq: AERI) has its sights set on global strategy as well. Aerie – which is developing a pipeline of treatments for glaucoma and other eye diseases and is beefing up its research and development team locally – is also well on its way pursuing regulatory approval in both Europe and Japan moving forward. "The company’s success to date, both clinical ly and financially, is what is allowing… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

How West Seattle-based GoodMed Clinic plans to avoid Qliance's fate
After primary care provider Qliance failed due to the changing health care environment and loss of contracts and patients, GoodMed Clinic is taking it slow and approaching a similar business model a little differently. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Coral Garnick Source Type: news

Seattle, King County and the Ballmer Group seek to tackle opioid epidemic
Seattle and King County plan to spend millions tackling the opioid epidemic and homelessness crisis. Those efforts will get a big assist from the foundation run by former Microsoft CEO Steve Ballmer and his wife, Connie. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Coral Garnick Source Type: news

Six month report: Niagara Falls cardiac cath lab saves 29 lives
A collaborative effort between Niagara Falls Memorial, Catholic Health ’s Mercy Hospital, Kaleida Health’s Buffalo General Medical Center and Erie County Medical Center Corp. September, the lab has performed 400 procedures already. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Tracey Drury Source Type: news

Blue Cross Blue Shield of Georgia enters agreement with VillageMD to lower care costs
Blue Cross Blue Shield of Georgia (BSBSGa) is partnering with primary care provider VillageMD in an effort to improve patient health and lower costs, two of today's hottest health-care topics. BSBSGa is the largest health benefits company in Georgia and first in the state to contract with Chicago-based VillageMD. VillageMD collaborated with Quality Care Providers Inc., Atlanta's largest independent network of primary care physicians. The agreement helps give BCBSGa customers access to QCPI's 1,600… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Ellie Hensley Source Type: news

German firm pledges $100M to expand N.C. operations
Global health care company Fresenius Kabi is expanding its manufacturing operations in Wilson County, a move spurred by a state grant awarded Tuesday. North Carolina’s Economic Investment Committee approved a Job Development Investment Grant for the company, which could pay out as much as $7.2 million over 12 years, if Fresenius Kabi meets certain job creation and investment targets. Under the terms of the grant, Fresenius Kabi has agreed to create 445 jobs over five years. Payments from the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Ben Graham Source Type: news

St. Jude commits to 1,800 new jobs, $1B investment within 6 years
The new positions will have an average wage of $33.20. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Elle Perry Source Type: news

Georgia Tech researcher heads to University of Oregon to lead new campus
The University of Oregon has tapped Robert Guldberg, head of the Parker H. Petit Institute for Bioengineering and Biosciences at Atlanta-based Georgia Tech, as executive director of its new Knight Campus. Guldberg will start in September 2018 leading the Phil and Penny Knight Campus for Accelerating Scientific Impact at the University of Oregon’s Eugene campus. Guldberg’s work focuses on regenerative medicine and bridging the world of research and entrepreneurship. “Bob describes himself… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Malia Spencer Source Type: news

Despite stormy quarter, Medtronic earnings beat Wall Street estimates
Medical-device giant Medtronic reported profits that beat Wall Street expectations Tuesday despite battling hurricanes and wildfires during its most recent quarter. The company’s adjusted second-quarter earnings totaled $1.46 billion, or $1.07 per share. That’s down from $1.56 billion, or $1.12 per share, but better than analysts’ estimated 98 cents per share. The company’s stock rose about 5 percent to $83.07 per share in afternoon trading Tuesday. Hurricane Maria ultimately cost Medtronic… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Katharine Grayson Source Type: news

Chief medical officer loses his job at United Medical Center
Just weeks after United Medical Center's chief medical officer offered forceful testimony against the District-owned hospital's operator, his contract has been terminated with UMC. Dr. Julian Craig, who has served as CMO of the hospital since 2015, will lose his contract to practice at the hospital starting next month, according to a letter sent by his attorney to members of the D.C. Council on Tuesday. In a letter signed by UMC Chairwoman LaRuby May, Craig was informed Nov. 17 that the hospital… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Chief medical officer at Raleigh company talks Epic integration
Raleigh-based health care technology company MD Interconnect – which has seen the number of users of its RapidConnect app grow from about 400 to 2,000 over the last eight months – has integrated offerings with Verona, Wisconsin-based health care software company Epic. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Flagship-backed cancer biotech Ensemble quietly shuts down
During its 13-year existence, the Cambridge biotech made waves by announcing a series of partnership deals with large drugmakers. But it raised relatively little in equity financing and never launched a clinical trial. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Maryland health exchange names new executive director
Michele S. Eberle has been named the new executive director for the Maryland Health Benefit Exchange, the organization that oversees the state's Affordable Care Act marketplace. Eberle has served as chief operating officer for the exchange since 2015. She will now take the top seat in the agency that facilitates enrollment in private health insurance and Medicaid plans for over 1.1 million Marylanders. The exchange's former chief, Carolyn A. Quattrocki, stepped down la te last year. The executive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Morgan Eichensehr Source Type: news

AMA suspends relationship with Outcome Health
The American Medical Association on Monday suspended its relationship with Outcome Health after the startup was accused of fraud. The Chicago-based AMA said it had no financial relationship with Outcome, per the Chicago Tribune. Outcome had donated screen time to the AMA for public service announcements regarding pre-diabetes. “In light of recent unfavorable reports in the media regarding Outcome Health, we requested that all AMA content displayed on any ContextMedia platforms be removed immediately,”… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Gina Hall Source Type: news

Swinging at Lou Gehrig's disease, Peninsula drug maker strikes out
After spending "hundreds of millions" of dollars over eight years on an experimental drug for people with amyotrophic lateral sclerosis, or ALS, a South San Francisco company's late-stage trial came up short. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Why this doctor returned to Genentech to give hemophilia patients a shot
Dr. Gallia Levy saw the early clinical data around a potential hemophilia A drug that Roche affiliate Chugai Pharmaceutical had developed. Now it was coming to Genentech, and Levy wanted to be there, too. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Fenway Sports adds consulting clients apart from Sox
Fenway Sports Management has added Boston-based hospital operator Steward Health Care and an undisclosed pharmaceutical company to its client roster, part of an effort to grow the agency ’s consulting division. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Eric Fisher Source Type: news

Biogen taps former Boston Scientific exec as next CFO
Four months after losing its longtime chief financial officer to another drugmaker, Biogen has appointed a former Boston Scientific executive to that post. Cambridge-based Biogen (Nasdaq: BIIB) said Tuesday that Jeffrey Capello will take over as CFO on Dec. 11. He succeeds Paul Clancy, who served in that role for a decade before decamping for Alexion Pharmaceuticals (Nasdaq: ALXN) in July. Capello has served for the past year as CFO of Beacon Heal th Options, a Boston-based behavioral health company.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Brown asks OHA's Allen to guarantee kids' CHIP coverage through April
Oregon's federal funding for the program will be exhausted in December. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Swinging at Lou Gehrig's disease, Peninsula drug maker strikes out
After spending "hundreds of millions" of dollars over eight years on an experimental drug for people with amyotrophic lateral sclerosis, or ALS, a South San Francisco company's late-stage trial came up short. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Cytokinetics ALS Drug Fails
Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of muscle, not nerves, it could have an impact on lung function in patients with amyotrophic lateral sclerosis, popularly known as Lou Gehrig's disease, a nerve-destroying disorder. It didn't work. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 21, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-Linked Myotubular Myopathy
SAN FRANCISCO, Nov. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatenin... Biopharmaceuticals Audentes Therapeutics, X-Linked Myotubular Myopathy, RECENSUS Study (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 21, 2017 Category: Pharmaceuticals Source Type: news

Sacramento County to pay UC Davis Health $98 million in legal settlement
The settlement resolves a lawsuit that UC Davis filed against the county in 2009, claiming that it failed to pay the health system for care delivered to indigent patients and jail inmates over the course of eight years. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2017 Category: Biotechnology Authors: Scott Rodd Source Type: news

Pharma firms tide over GST impact
Pharma firms had seen their revenues negatively impacted in the first quarter due to destocking ahead of the GST implementation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2017 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets EIR for Vizag plant, but inspection not closed
It, however, said the US Food and Drug Administration has not closed the inspection and the manufacturing site's status remains unchanged. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2017 Category: Pharmaceuticals Source Type: news

Cap on non-economic malpractice damages goes to Wisconsin Supreme Court
The medical malpractice case of a Milwaukee woman who won a $15 million jury verdict after her four extremities were amputated is set for a Wisconsin Supreme Court review. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 20, 2017 Category: Biotechnology Authors: Rich Kirchen Source Type: news

Virgin Pulse moving global HQ from Framingham
Virgin Pulse has announced it will move its global headquarters out of Massachusetts, with plans to open a new corporate home base in downtown Providence. The corporate wellness company, which has been located in Framingham, announced that its new office in the Providence Journal building at 75 Fountain St. will become the home to 300 employees by 2021. Currently the space is home to 100 full-time Virgin Pulse employees. The company said in a rele ase that it selected Providence as its global… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 20, 2017 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Knute Buehler talks safe opioid prescribing practices
Orthopedists tend to be high prescribers, but there are ways to cut back (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 20, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news